Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

NGL Fine Chem Ltd.

BSE: 524774 | NSE: NGLFINE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE887E01022 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Apr 21, 14:56
2250.05 -77.90 (-3.35%)
Volume
AVERAGE VOLUME
5-Day
612
10-Day
632
30-Day
595
59
  • Prev. Close

    2327.95

  • Open Price

    2315.00

  • Bid Price (Qty.)

    2250.15 (5)

  • Offer Price (Qty.)

    2264.60 (4)

NSE Live

Apr 21, 14:56
2256.10 -43.20 (-1.88%)
Volume
AVERAGE VOLUME
5-Day
8,475
10-Day
7,221
30-Day
6,304
2,045
  • Prev. Close

    2299.30

  • Open Price

    2325.00

  • Bid Price (Qty.)

    2256.10 (2)

  • Offer Price (Qty.)

    2265.40 (1)

Financials

Balance Sheet of NGL Fine Chem (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 3.09 3.09 3.09 3.09 3.09  
Total Share Capital 3.09 3.09 3.09 3.09 3.09  
Reserves and Surplus 279.35 259.54 219.46 200.13 151.37  
Total Reserves and Surplus 279.35 259.54 219.46 200.13 151.37  
Total Shareholders Funds 282.43 262.63 222.55 203.22 154.46  
Minority Interest 0.00 0.00 0.00 0.00 0.00  
NON-CURRENT LIABILITIES  
Long Term Borrowings 25.34 0.74 2.07 3.44 6.13  
Deferred Tax Liabilities [Net] 2.48 2.19 1.37 1.91 2.38  
Other Long Term Liabilities 0.17 0.15 0.09 0.17 0.20  
Long Term Provisions 4.00 3.23 2.70 2.55 2.46  
Total Non-Current Liabilities 31.99 6.32 6.24 8.06 11.16  
CURRENT LIABILITIES  
Short Term Borrowings 47.82 31.70 28.41 23.43 4.83  
Trade Payables 57.52 49.39 24.59 37.16 29.53  
Other Current Liabilities 12.15 4.70 4.61 4.47 7.15  
Short Term Provisions 1.48 0.81 0.69 0.59 0.63  
Total Current Liabilities 118.97 86.59 58.29 65.65 42.14  
Total Capital And Liabilities 433.39 355.54 287.08 276.93 207.77  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 142.12 85.30 87.59 88.31 63.62  
Intangible Assets 0.40 0.12 0.17 0.30 0.50  
Capital Work-In-Progress 49.73 45.52 26.31 6.43 12.35  
Fixed Assets 192.24 130.94 114.07 95.05 76.48  
Non-Current Investments 0.00 0.00 0.00 0.00 0.00  
Deferred Tax Assets [Net] 0.00 0.00 0.00 0.00 0.00  
Long Term Loans And Advances 0.00 0.00 0.00 0.00 0.00  
Other Non-Current Assets 5.62 11.78 10.20 8.23 6.76  
Total Non-Current Assets 198.01 142.87 124.42 103.44 83.24  
CURRENT ASSETS  
Current Investments 59.66 53.59 39.46 28.72 29.07  
Inventories 51.27 43.30 26.99 56.01 37.85  
Trade Receivables 81.55 89.62 65.87 63.98 37.56  
Cash And Cash Equivalents 5.86 1.72 13.04 0.83 4.78  
Short Term Loans And Advances 0.00 0.00 0.00 0.00 0.00  
OtherCurrentAssets 37.03 24.43 17.29 23.96 15.27  
Total Current Assets 235.38 212.67 162.66 173.49 124.53  
Total Assets 433.39 355.54 287.08 276.93 207.77  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 13.47 19.86 14.11 14.83 7.86  
BONUS DETAILS  
Bonus Equity Share Capital 0.91 0.91 0.91 0.91 0.91  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value 0.00 0.00 0.00 0.00 0.00  
Non-Current Investments Unquoted Book Value 0.00 0.00 0.00 0.00 0.00  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value 59.66 53.59 39.46 28.72 0.00  
Current Investments Unquoted Book Value 0.00 0.00 0.00 0.00 29.07  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347